Laurence N. Raymond
Nessuna posizione attualmente
Profilo
Laurence N.
Raymond co-founded ReceptoPharm, Inc in June 4, 2001 and currently serves as Chief Scientific Officer.
He was a Consultant at BioTherapeutics, Inc (known as Phylomed, Inc.) from 1997 to May 2001.
Previously, Dr. Raymond was an Associate Fellow at the Sandoz Research Institute.
Prior to that he was Manager of Research and Development for Pel-Freez Biologicals and Director of the Hybridoma Lab for the University of Arkansas Biotechnology Center in Fayetteville.
Dr. Raymond was a Principal at the University of New Mexico School of Medicine in Albuquerque and at the University of Arizona in Tucson.
He received a Bachelor's degree in Nutritional Biochemistry, a Master's of Science Degree in Animal Physiology, and a PhD in Microbiology and Immunology all from the University of Arizona.
Precedenti posizioni note di Laurence N. Raymond
Società | Posizione | Fine |
---|---|---|
BioTherapeutics Corp | Corporate Officer/Principal | 01/05/2001 |
University of Arizona | Corporate Officer/Principal | - |
Sandoz Research Institute | Corporate Officer/Principal | - |
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Laurence N. Raymond
University of Arizona | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
BioTherapeutics Corp | Consumer Non-Durables |
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Health Technology |
Sandoz Research Institute |
- Borsa valori
- Insiders
- Laurence N. Raymond